---
title: "Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286840623.md"
description: "Nanjing's Leads Biolabs Co., Ltd. revealed today that their exclusive PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), has been approved by the Center for Drug Evaluation. This announcement was made under the Stock Code."
datetime: "2026-05-19T01:38:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286840623.md)
  - [en](https://longbridge.com/en/news/286840623.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286840623.md)
---

# Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC

Nanjing's Leads Biolabs Co., Ltd. revealed today that their exclusive PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), has been approved by the Center for Drug Evaluation. This announcement was made under the Stock Code 9887.HK.

### Related Stocks

- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [09887.HK](https://longbridge.com/en/quote/09887.HK.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [United Labs says China regulator clears TUL108 injection for clinical trial](https://longbridge.com/en/news/286902656.md)
- [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)
- [Fingerprint Cards AB Bets on Merger-Led Turnaround](https://longbridge.com/en/news/286333864.md)